Sera Prognostics Inc
NASDAQ:SERA
Sera Prognostics Inc
NASDAQ:SERA
Price:
1.99
USD
-1.97%
Market Closed
Market Cap:
$76.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sera Prognostics Inc
NASDAQ:SERA
|
US |
|
Ying Hai Group Holdings Company Ltd
HKEX:8668
|
MO |
|
American Rare Earths Ltd
ASX:ARR
|
AU |
|
Third Coast Bancshares Inc
NASDAQ:TCBX
|
US |
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
KR |
|
Delton Cables Ltd
BSE:504240
|
IN |
|
RE&S Holdings Ltd
SGX:1G1
|
SG |
|
H
|
Hwa Fong Rubber Ind Co Ltd
TWSE:2109
|
TW |
|
Kino Indonesia Tbk PT
IDX:KINO
|
ID |
|
T
|
TST Group Holding Ltd
TWSE:4439
|
TW |
|
360 Capital Group Ltd
ASX:TGP
|
AU |
|
Sixth Street Specialty Lending Inc
NYSE:TSLX
|
US |
|
PVR INOX Ltd
NSE:PVRINOX
|
IN |
|
Payroll Inc
TSE:4489
|
JP |
|
CNO Financial Group Inc
NYSE:CNO
|
US |
|
Kranti Industries Ltd
BSE:542459
|
IN |
|
Steadfast Group Ltd
ASX:SDF
|
AU |
|
Eni SpA
XETRA:ENI
|
IT |
|
F
|
Fulcrum Metals PLC
LSE:FMET
|
UK |
|
C
|
Cathay Consolidated Inc
TWSE:1342
|
TW |
Relative Value
The Relative Value of one
SERA
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 1.99 USD,
Sera Prognostics Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SERA Relative Value
HIDDEN
Multiples Across Competitors
SERA Competitors Multiples
Sera Prognostics Inc Competitors
Sera Prognostics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Sera Prognostics Inc
NASDAQ:SERA
|
77.5m USD | 956.8 | -2.4 | -1.1 | -1.1 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
366.3B USD | 6 | 87.5 | 14.5 | 20.2 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.9B USD | 109.6 | -1 710.6 | 15 890.6 | -1 794.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.8B USD | 5.2 | 24.7 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.6B USD | 5.8 | 20.2 | 12.6 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.6B USD | 9.6 | 29.2 | 22 | 23 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.5 | 17.6 | 13 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68B AUD | 3.2 | 35.1 | 11.5 | 14.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
